Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|March 7, 2008
Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinomaReinhold Ramoner, Andrea Rahm, Hubert Gander, et al.
Nutrients|October 23, 2014
The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentAndrea Dueregger, Isabel Heidegger, Philipp Ofer, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2006
Antigen-independent immune responses after dendritic cell vaccinationNicolai Leonhartsberger, Reinhold Ramoner, Thomas Putz, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Clinically insignificant improvement of prostate cancer prediction by addition of sex steroid hormones and SHBG serum levels to serum PSA, fPSA%, and age in a screening settingIsabel Heidegger, Marina Popovscaia, Reinhold Ramoner, et al.
Cancer Immunology, Immunotherapy : CII|September 2, 2006
Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cellsThomas Putz, Reinhold Ramoner, Hubert Gander, et al.
BJU International|June 3, 2011
Increased incidence of Leydig cell tumours of the testis in the era of improved imaging techniquesNicolai Leonhartsberger, Reinhold Ramoner, Friedrich Aigner, et al.
The Prostate|January 27, 2004
Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cellsKarina Pfeil, Iris E Eder, Thomas Putz, et al.
Public Health Nutrition|November 30, 2018
Traditional v. modern dietary patterns among a population in western Austria: associations with body composition and nutrient profileSabrina Egg, Judith Erler, Bernhard Perktold, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 2006
IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responsesClaudia Falkensammer, Karin Jöhrer, Hubert Gander, et al.
The Prostate|April 6, 2004
Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expressionAlfred Hobisch, Matthias Fiechtl, Boe Sandahl-Sorensen, et al.
Pageof 3